McLane Research Laboratories Inc

The Nigrovic lab studies basic immune mechanisms of arthritis and other rheumatic diseases in adults and children. This work employs both human specimens and murine model systems.

Center Overview Cape Cod Research Institute (CCRI) was established in August 2003 as a not-for-profit Corporation to further clinical research and medical education in the area of cardiology and heart disease. Located in Hyannis, Massachusetts, CCRI allows patients to access sophisticated devices, procedures and pharmaceuticals without having to travel to tertiary centers; assuring patients that all level of cardiac care can be offered by the local physicians in whom they have come to trust. CCRI is a fully functioning research facility which is legally independent from the Cape Cod Healthcare, Inc and the physicians with whom we work. The infrastructure of the Cape Cod Research Institute ensures that Physician Investigators, Industry Sponsors and Subjects who participate in clinical studies have access to legal, ethical, scientific and regulatory expertise. A staff of knowledgeable research nurses and technicians carefully track and maintain patient data. Each clinical trial is carefully scrutinized for ethics and patient safety by the staff of CCRI as well as from an independent Instititutional Review Board. CCRI serves as the institutional infrastructure that encourages and supports its physician scientists by serving as an interface between clinical investigators and sponsors of clinical trials. CCRI provides a high level of clinical trial services to help investigators compete and meet the demands on industrial sponsors. For sponsors, we provide high data quality and quick subject enrollment. We strictly adhere to Good clinical Practice (GCP). Services to Primary Investigators include: Assistance with strategy and proposal development for corporate-sponsored and investigator-initiated clinical trials.

BTC of New Bedford is a multi-specialist clinical research site dedicated to enhancing care through rigorous clinical studies across various therapeutic areas for over a decade. They prioritize participant safety and adhere to strict FDA guidelines, ensuring ethical conduct throughout all studies. Offering no-cost participation, BTC also provides compensation for participants' time and travel expenses, fostering a supportive environment for clinical research. Participants are fully informed of study details and retain the option to withdraw at any point without consequence. Generated from the website